8-K current report · filed Jul 29, 2026

Bausch Health Companies Inc (BHC) 8-K Current Report: July 29, 2026

Item EX-99.1Item 2.02BHC overview

Short answer

Bausch Health Companies Inc (BHC) filed an 8-K current report with the SEC on July 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Press release announces Bausch Health’s results for quarter ended June 30, 2026.

Bausch Health Companies Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release announces Bausch Health’s results for quarter ended June 30, 2026
  • Exhibit 99.1 contains operating results and other financial information for the quarter
  • Investors should review Exhibit 99.1 for revenue, profitability, cash flow and guidance details

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $2.85B, up 13% reported and 11% organic, indicating broad-based operating momentum
  • GAAP EPS $0.68 versus $0.40, while adjusted EPS rose 40% to $1.26
  • Adjusted EBITDA $1.075B, up 28%, with operating cash flow surging 132% to $671M
  • Salix revenue grew 21% organically, led by Xifaxan growth of 26%; Bausch + Lomb grew 8% organically
  • 2026 guidance raised: revenue $10.790B-$11.040B, adjusted EBITDA $4.050B-$4.175B, adjusted operating cash flow $1.400B-$1.475B

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Bausch Health Companies Inc 8-K filings

Get the next BHC 8-K as it lands

Follow BHC for push alerts, or ask the research agent what this filing means.